Gopaldas Visram AND Company Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Gopaldas Visram AND Company Limited Pharmaceutical Export Portfolio Dataset — 2 Products, $5.2M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Gopaldas Visram AND Company Limited — Pharmaceutical Exporter Profile (2026) | 2 Products, $5.2M Trade | TransData Nexus

Gopaldas Visram AND Company Limited

Indian Pharmaceutical Exporter · Vitamins & Supplements Specialist · $5.2M Total Trade · DGFT Verified

Gopaldas Visram AND Company Limited is an Indian pharmaceutical exporter with a total trade value of $5.2M across 2 products in 2 therapeutic categories. Based on 344 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Zinc ($3.9M), Hydrocortisone ($1.2M), .

Gopaldas Visram AND Company Limited — Export Portfolio & Destination Treemap

Gopaldas Visram AND Company Limited pharmaceutical export portfolio — 2 products across 2 therapeutic categories. Source: Indian Customs (DGFT).

Who is Gopaldas Visram AND Company Limited? — Company Overview & Market Position

Gopaldas Visram & Company Limited (GVCL) is a prominent Indian pharmaceutical exporter specializing in the development and manufacturing of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Established in 1945, the company has over 70 years of experience in the pharmaceutical and cosmeceutical sectors. GVCL operates from its headquarters located at Persian Apartment, Plot No-434, Ground Floor V P Road, Andheri West, Mumbai, Maharashtra 400058. The company is registered under the Corporate Identification Number (CIN) U52100MH2005PLC156917. As of the latest available data, GVCL has an authorized share capital of ₹15.00 crore and a paid-up capital of ₹9.99 crore. The company employs approximately 259 professionals. GVCL's official website is gopaldasvisram.com.

What Does Gopaldas Visram AND Company Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Zinc$3.9M 2Hydrocortisone$1.2M

Product Portfolio — Top 2 by Export Value

Gopaldas Visram AND Company Limited exports 2 pharmaceutical products across 2 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Zinc	Vitamins & Supplements	$3.9M	224	5.0%	3
2	Hydrocortisone	Corticosteroids	$1.2M	120	1.9%	11

Gopaldas Visram AND Company Limited exports 2 pharmaceutical products across 2 therapeutic categories with a total export value of $5.2M. The top category is Vitamins & Supplements (76.3% of portfolio), followed by Corticosteroids (23.7%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Gopaldas Visram AND Company Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

GVCL boasts a manufacturing area exceeding 220,000 square feet, equipped with state-of-the-art Quality Assurance (QA) and Quality Control (QC) laboratories. The company's manufacturing facilities are WHO-GMP certified, ISO 9001:2015 certified, and US FDA approved, ensuring adherence to international quality standards. GVCL's manufacturing capabilities encompass the production of liquids, ointments, powders, granules, and dusting powders, catering to a diverse range of pharmaceutical and cosmeceutical products.

3Key Leadership

GVCL's leadership team comprises experienced professionals dedicated to the company's growth and operational excellence. Mr. Dinesh Vallabhdas Thakker serves as the Managing Director, overseeing the comprehensive affairs of the group, including sales and marketing. Mr. Mukund Vallabhdas Thakker manages the operational activities of the company, bringing expertise in manufacturing and project management. Mr. Chandresh Vallabhdas Thakker, a commerce and law graduate from Mumbai University, oversees the company's legal and financial affairs. Other key executives include Mr. Chinubhai Shantilal Shah, Mr. Mukesh Chandrakant Khagram, Mr. Jay Mukund Thakker, and Ms. Rita Rajesh Kamani, who contribute to the strategic direction and management of GVCL.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Gopaldas Visram AND Company Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

GVCL has established a presence in several regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company's manufacturing facilities are US FDA approved, indicating compliance with stringent US regulatory standards. GVCL's products are WHO-GMP certified, ISO 9001:2015 certified, and US FDA approved, facilitating market access in these regions. The company's adherence to international quality standards enhances its credibility and acceptance in these regulated markets.

2Emerging Markets

GVCL has expanded its reach into emerging markets, including Africa, Latin America, and Southeast Asia. The company's WHO-GMP certification and adherence to international quality standards enable it to meet the regulatory requirements of these regions. GVCL's focus on quality and compliance positions it favorably to penetrate and establish a strong presence in these emerging markets.

3Geographic Strategy

GVCL's export portfolio is concentrated, with its top two products—Zinc and Hydrocortisone—accounting for 100% of its export value. This concentration indicates a focused product strategy, which may expose the company to risks associated with market fluctuations in these specific products. Diversifying its product range could mitigate such risks and enhance GVCL's resilience in the global market.

Gopaldas Visram AND Company Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

GVCL's manufacturing facility is registered with the US FDA, indicating compliance with US regulatory standards. The facility has undergone FDA inspections, with known issues observed during these inspections. The FDA is responsible for inspecting drug manufacturing facilities for violations of good manufacturing practices, such as a lack of documented drug quality testing or contaminated equipment. GVCL's facility has been subject to FDA inspections, and issues have been observed during these inspections.

2WHO & EU GMP

GVCL's manufacturing facilities are WHO-GMP certified, ensuring adherence to international quality standards. The company also holds ISO 9001:2015 certification, reflecting its commitment to quality management systems. However, there is no specific information available regarding EU GMP certification or EDQM status.

3CDSCO & Indian Regulatory

GVCL holds manufacturing licenses from the Central Drugs Standard Control Organisation (CDSCO), the national regulatory authority in India. The company has obtained necessary approvals from state drug controllers and export No Objection Certificates (NOCs), facilitating its export operations. GVCL's compliance with Indian regulatory requirements underscores its commitment to quality and safety in pharmaceutical manufacturing.

Gopaldas Visram AND Company Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

GVCL operates in a competitive landscape, with several companies offering similar pharmaceutical formulations. While specific market share data is not available, GVCL's focus on quality and compliance with international standards positions it favorably in the market. The company's WHO-GMP certification, ISO 9001:2015 certification, and US FDA approval enhance its credibility and competitiveness.

2Key Differentiators

GVCL's key differentiators include its extensive experience of over 70 years in the pharmaceutical and cosmeceutical sectors, a manufacturing area exceeding 220,000 square feet, and adherence to international quality standards such as WHO-GMP and ISO 9001:2015 certifications. The company's US FDA approval further underscores its commitment to quality and regulatory compliance.

3Strategic Position

GVCL's current strategic direction focuses on the development and manufacturing of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. The company's adherence to international quality standards and regulatory approvals positions it well in the global market. Future strategic initiatives may include diversifying its product portfolio and expanding its presence in emerging markets to mitigate concentration risks and enhance growth opportunities.

Buyer Due Diligence Brief — Evaluating Gopaldas Visram AND Company Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

GVCL has a track record of over 70 years in the pharmaceutical and cosmeceutical sectors, indicating reliability and experience. The company's manufacturing facilities are WHO-GMP certified, ISO 9001:2015 certified, and US FDA approved, reflecting its commitment to quality and compliance. However, known issues have been observed during FDA inspections, which may impact the company's reliability.

2Certifications to Verify

Importers should verify the following certifications to ensure product quality and regulatory compliance:

FDA Registration: Confirm the facility's registration status with the US FDA.

WHO-GMP Certification: Verify the facility's certification status with the World Health Organization's Good Manufacturing Practices.

EU GMP Certification: Check for certification with the European Union's Good Manufacturing Practices.

Frequently Asked Questions — Gopaldas Visram AND Company Limited

How many pharmaceutical products does Gopaldas Visram AND Company Limited export from India?

Gopaldas Visram AND Company Limited exports 2 pharmaceutical products across 2 therapeutic categories. The top exports are Zinc ($3.9M), Hydrocortisone ($1.2M). Total export value is $5.2M.

What is Gopaldas Visram AND Company Limited's total pharmaceutical export value?

Gopaldas Visram AND Company Limited's total pharmaceutical export value is $5.2M, based on 344 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Gopaldas Visram AND Company Limited cover?

Gopaldas Visram AND Company Limited exports across 2 therapeutic categories. The largest are Vitamins & Supplements (76.3%, 1 products), Corticosteroids (23.7%, 1 products).

Get Full Gopaldas Visram AND Company Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.